12:00 AM
 | 
Mar 22, 1999
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Abgenix preclinical data

ABGX published in Cancer Research that low doses of its antibody against the EGFr were able to stop proliferation of tumor cells in...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >